Biology of Blood and Marrow Transplantation
Volume 15, Issue 9 , Pages 1094-1099 , September 2009

Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation

  • Jonas A. de Souza

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medical Center, Chicago, Illinois
    • ,
  • Rima M. Saliba

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Poliana Patah

      Affiliations

    • Hospital Sirio Libanes, Hematology Service, Sao Paulo, Brazil
    • ,
  • Gabriela Rondon

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Rachel Ribeiro

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Leandro de Padua Silva

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Muzaffar H. Qazilbash

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Chitra Hosing

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Uday Popat

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Yvonne Efebera

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Richard E. Champlin

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Marcos de Lima

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • Corresponding Author InformationCorrespondence and reprint requests: Marcos de Lima, MD, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.

Received 9 January 2009 ,Accepted 8 May 2009.

  • Image Result

    Cumulative incidence of a creatinine level above 1.5 mg/dL in the first year after transplantation. The GFR estimated by the CG method did not have an impact on the incidence of renal failure after tr

    Cumulative incidence of a creatinine level above 1.5 mg/dL in the first year after transplantation. The GFR estimated by the CG method did not have an impact on the incidence of renal failure after transplant.

  • Image Result
    Cumulative incidence of renal failure requiring dialysis in the first year after transplantation. The GFR as estimated by the CG equation did not have an impact on the incidence of renal failure requi

    Cumulative incidence of renal failure requiring dialysis in the first year after transplantation. The GFR as estimated by the CG equation did not have an impact on the incidence of renal failure requiring dialysis.

 Financial disclosure: See Acknowledgments on page 1099.

PII: S1083-8791(09)00234-1

doi: 10.1016/j.bbmt.2009.05.006

Biology of Blood and Marrow Transplantation
Volume 15, Issue 9 , Pages 1094-1099 , September 2009

Article Tools

* Image Usage & Resolution